Production (Stage)
Elevation Oncology, Inc.
ELEV
$0.3817
$0.00150.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 16.21M | 16.11M | 15.37M | 15.02M | 14.42M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.68M | 44.70M | 42.01M | 39.70M | 38.57M |
| Operating Income | -45.68M | -44.70M | -42.01M | -39.70M | -38.57M |
| Income Before Tax | -47.95M | -44.44M | -41.91M | -39.66M | -39.32M |
| Income Tax Expenses | 38.00K | 43.00K | 43.00K | 42.00K | 36.00K |
| Earnings from Continuing Operations | -47.99 | -44.49 | -41.95 | -39.70 | -39.35 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -47.99M | -44.49M | -41.95M | -39.70M | -39.35M |
| EBIT | -45.68M | -44.70M | -42.01M | -39.70M | -38.57M |
| EBITDA | -45.66M | -44.68M | -41.98M | -39.67M | -38.53M |
| EPS Basic | -0.81 | -0.78 | -0.79 | -0.82 | -1.00 |
| Normalized Basic EPS | -0.47 | -0.47 | -0.48 | -0.50 | -0.61 |
| EPS Diluted | -0.81 | -0.78 | -0.79 | -0.82 | -1.00 |
| Normalized Diluted EPS | -0.47 | -0.47 | -0.48 | -0.50 | -0.61 |
| Average Basic Shares Outstanding | 236.42M | 229.06M | 212.35M | 195.65M | 165.04M |
| Average Diluted Shares Outstanding | 236.42M | 229.06M | 212.35M | 195.65M | 165.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |